QUN XU: Open Payments
NPI 1689837684 · CAMILLUS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,611 in 80 payments from 16 companies in 2025. Trend: 2023 $2,280 · 2024 $2,289 · 2025 $1,611
Food & beverage: $1,527Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $315 |
| Janssen Biotech, Inc. | 4 | $210 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $182 |
| Phathom Pharmaceuticals, Inc. | 10 | $147 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $135 |
| Gilead Sciences, Inc. | 5 | $101 |
| Lilly USA, LLC | 5 | $85 |
| PFIZER INC. | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $66 |
| Aimmune Therapeutics, Inc. | 3 | $66 |
Products named: TREMFYA, ENTYVIO, VOQUEZNA, XIFAXAN, RINVOQ, CREON, OMVOH, DUPIXENT.
Industry payments across NY — which companies pay providers there.
